Rib-X Pharma files for IPO to finance antibiotics providing superior coverage
29 November 2011
Nancy Faigen
Please Login to read the full article.
29 November 2011
Nancy Faigen
nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Sub-prime Rib-X chops offer price then postpones IPO as cash dwindles
- US bill aims to provide exclusivity, other incentives for antibiotic makers
- VCs dump $67.5M into Rempex (rump Mpex) for ESKAPE efflux pump inhibitors
- Cempra dives into tough IPO pool, filing $86M IPO for Phase II antibiotics
FEATURES
Other Informa Features
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
